AstraZeneca (BSP:A1ZN34) Other Long Term Assets : R$52,577 Mil (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is AstraZeneca Other Long Term Assets?

AstraZeneca's other long-term assets for the quarter that ended in Mar. 2025 was R$52,577 Mil.

AstraZeneca's quarterly other long-term assets increased from Sep. 2024 (R$48,295 Mil) to Dec. 2024 (R$50,998 Mil) and increased from Dec. 2024 (R$50,998 Mil) to Mar. 2025 (R$52,577 Mil).

AstraZeneca's annual other long-term assets increased from Dec. 2022 (R$27,874 Mil) to Dec. 2023 (R$36,386 Mil) and increased from Dec. 2023 (R$36,386 Mil) to Dec. 2024 (R$50,998 Mil).

AstraZeneca Other Long Term Assets Historical Data

The historical data trend for AstraZeneca's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Other Long Term Assets Chart

AstraZeneca Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

28,172.38

37,118.76

27,874.06

36,385.91

50,998.26

AstraZeneca Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															36,208.13	41,085.17	48,295.16	50,998.26	52,577.21

AstraZeneca Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

AstraZeneca Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (BSP:A1ZN34) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK ZEGA:Germany ZEG:Germany ZEG:Germany ZEG:Germany ZEGA:Germany ZEG:Germany AZNA:Austria AZN:Argentina

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

AstraZeneca Headlines

No Headlines